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Dermal-epidermal separation (DES) could be pro-
duced in vivo, 6 h after the injection of sera taken from 
patients with bullous pemphigoid into the dorsal skin of 
H artley guinea pigs. DES did not occur when antihuman 
I gG rabbit serum was injected prior to the injection of 
t he sera taken from patients with bullous pemphigoid. 
W hen IgG fraction from the patient 's sera was injected, 
D ES was also observed. Histologic findings in the skin 
specimens in vivo with concentrated sera or IgG fraction 
have shown DES, some cell infiltrations of neutrophils, 
eosinopbils, and some lymphocytes similar to the skin 
le sions of bullous pemphigoid patients. Various re-
a gents, such a s colchicine, cytochalasin B, EDTA, and 
steroid were injected prior to the IgG fraction injection. 
D ES and the migration of polymorphonuclear (PMN) 
leukocytes were inhibited by the preinjection of these 
r eagents. These observations suggest that the migration 
o f PMN leukocy tes was necessary for the formation of 
DES. When IgG fraction w as injected into C3-inacti-
v ated guinea pigs with cobra venom factor, DES was 
inhibited, whereas DES was not completely inhibited 
w hen IgG fraction was injected into C4 -deficient guinea 
pig s . These results suggested that an alternative path-
w ay may be necessary for DES. 
Bullo u s pe mphi goid (BP) a ntibodies fail ed to produce de r-
mal-epiderma l sepa ra tio n (DES ) in vit ro , a lt hough t he p attern 
of ant ibod y binding to t he base m e n t m embra ne zo ne (BMZ) 
was ide n t ical to t hat de m o nstrated by immunoelectron micros-
cop y in skin lesion s o f BP pat ie n ts [1] . In a previous study, 
norm al huma n s kin was cultured with sera, IgG fractions, and 
b li ster fluids (BF) fro m t he p atients wit h BP. DES was ob -
ser ved only in the skin expla nts cultured wi t h BF [2]. DES was 
not o bserved in skin expla nts cultured wi t h heat-inactiva ted 
BF, n e u t rali zed BF wi t h a n t icomple m ents a n t ibody, o r a~ ­
macr oglobulin. P emphigoid a ntibody m ediated the attachmen t 
o f p eriphe ra l blood le ukocytes at t he de rma l-epide rma ljunction 
o f huma n skin [3]. In t his study, DES in vivo occurred a fte r 
t he injection o f BP a n t ibody into t he do rsal skin of H a r t ley 
gu inea pigs. In additio n , migratio n o f poly morphonuclear 
(P M N) leukocytes to t he uppe r dermis was o bser ved in these 
s k in s pec ime n s. As a result o f these observat ion s, t he effects of 
PMN leukocytes and t he comple m ent for the fo rmatio n o f DES 
w e re investigated. 
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CVF: cobra venom facto r 
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PMN: polymorphonuclea r 
MATERIALS A ND METHODS 
Seru.m of BP Patients and Preparat1:on of IgG Fraction. (Table I) 
Serum used for experiments was obtained and pooled from 2 un -
treated patients wi th BP. The t ite r of t he ant i-BMZ ant ibody (IgG) 
was 1280. The serum was t hen concent rated wi th Amicon Diaflow 
membrane (YM10) and showed a t ite r of 5120. lgG fractions from 
pooled sera of t he patients were prepared by protein A-Sepha rose CL4B 
chromatography. The protein concentration of t his lgG fraction was 
prepared as 11 mg/ ml which conta ined a 640 t ite r of BP ant ibody. For 
t he control study, normal human sera were obtained from 8 healt hy 
adul t individuals. T hey were concent rated by Amicon membrane and 
the lgG concent ration was adjusted to 55.3 mg/ml. Alte rnatively, lgG 
was purified using protein A column. 
Produ.ct£on of DES In V£vo 
Male Hart ley guinea pigs were used for t he study of blister fo rmation 
(DES ) in vivo. Approximately 0.2 ml of serum , concent rated serum, 
and lgG from BP patients was injected in t radermally into a shaved 
back area of each animal. Using local anesthesia wi th procaine, biopsies 
were taken from the injection site 1, 3, 6, 12, 24, and 48 h after t he 
injection was given. These skin specimens were then examined by 
histologic (hematoxylin and eosin staining methods) and immunoflu -
orescence (IF) techniques. 
Effects of A ntihuman IgG Serum In. Vivo 
Antihuman lgG rabbi t serum (0.2 ml) was preinjected into t he guinea 
pig 30 min before t he injection of concent rated serum from BP patients. 
As a cont rol, 0.2 ml of 0.9% NaCl solu t ion was also preinjected. Skin 
biopsies were ta ken a nd examined by histologic techniques as men-
t ioned above. 
Effects of Some Reagents on DES In. Vivo 
One millimolar colchicine, 20 pM cytochalasin B, 1 mM EDT A, and 
4 mg/ ml betamethasone were used in this experiment. Two-ten ths of 
a millili ter of each reagent was injected 30 min before t he injection of 
concent rated serum of lgG fraction from BP patients. Biopsies were 
taken from t he injection site 3, 6, 12, a nd 24 h afte r the injection was 
given, and we then examined t he inhibitory effects of these reagents 
on DES. 
Inhibition of DES in C3-lnactivated Guinea Pigs and C4- Deficien.t 
Gu.inea Pigs 
BP lgG fractions were injected int radermally in to the dorsal skin of 
C3- inactivated guinea pig wi t h cobra venom factor (CVF) . Biopsies 
were taken from t he injection site 3, 6, 12, and 24 h after the injection 
was given and examined histologically. CVF was obtained from Cordis 
Laboratories (Cat. No. 750-005, Lot No. 54 111 ). T wenty units of CVF 
per 100 g of body weight injected i.p. or i.v. in to guinea pigs will cause 
their hemolytic C3 levels to be lowered by 95% wit hin 3- 4 h afte r 
injection. This effect can persist for at least 3- 4 days ( 4]. BP lgG 
fractions were injected into t he dorsal skin of C4-defi cient guinea pigs 
a nd t he biopsies were t hen taken in the same manner described above. 
C4-delicient gu inea pigs were kindly donated by P rof. K. Inoue from 
t he Department of Bacte riology at. Osaka University. A colony of t hese 
a nima ls is now being established [5). 
RESU LTS 
D ES I n Vivo (T able ll) 
DES was observed histologically 6 h after t he injection into 
t he guinea pig of co nce n t rated serum of IgG fractio n from B P 
patien ts. Twe nty- four hours after t he injectio n , DES occurred 
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in 11 of 14 cases injected with concentrated BP serum and in 
7 of 10 cases injected with lgG fraction from BP patients. As a 
cont rol, concent rated normal human serum or normal lgG 
fract ions were app lied in t he same manner. DES was observed 
in only 1 out of 8 experiments 48 h after t he injection (Table 
II) . In addit ion, histo logic findin gs in the sk in specimens have 
shown all to be infilt rated by neut rophils, eosinophils, and 
some lymphocytes at the upper dermis, inside t he blister c~v i ~y, 
and in perivascula r areas. Most of the inflam matory (mfll-
t rated) cell s consisted of PMN leukocytes 1- 48 h after injec-
tions, alt hough some scattered eosinophils and l ymph~cytes 
were also observed t here. Especially in t he early stage of DES 
formation, 3-6 h after injections, t he hi stology showed inflam-
mato ry PMN leukocytes close to the dermal-epidermal jl!nc-
tion. In addition , linea r deposits of human lgG and C3 gumea 
pig were obse rved at t he BMZ in these skin specimens. At 12-
24 h 11/ 14 guinea pigs treated with concentrated BP serum 
had DES but by 48 h 9/14 had DES. A similar effect was 
obse rved with BP lgG fraction. We do not know the clear 
reason· however it was speculated t hat eit her reepithelization 
might have occ~rred after 48 h or that the blister might have 
reso lved. 
Effects of Antihuman JgG Serum on DES In Vivo 
DES was inhibi ted by t he preinjection of antihuman IgG 
serum prior to t he injection of concentrated serum or IgG 
fraction from BP patients. IF study showed that binding of BP 
IgG to t he BMZ was also inhibited. 
Effect of Some Reagents on DES In Vivo (Table III, Fig 1) 
DES was inhibited by t he preinjection of colchicine and 
cytochalasin B. In addit ion, t he migration of leukocytes was 
a lso successfully inhibited by colchicine, alt hough not success-
fu lly by cytochalasi n B. 
EDT A and betamethasone inhibited DES and the migration 
of leukocytes; on t he other hand, DES and the migration of 
leukocytes were not inhibited by the preinjection of NaCl which 
acted as t he control. 
Inh ibition of Dermal-Epidermal Separation in C3- Inactiuated 
Guinea Pigs and C4- Deficient Guinea Pigs (Table IV) 
DES was inhibited in C3-inactivated gu inea pigs, with no 
PMN cell in fi ltrations being observed in either animal. DES 
was observed in 2 of 6 C4-deficient guinea pigs. The C3 level 
Serum 
Concen-
t rated 
serumll 
TABLE I. Serum and /gO fraction from BP patients 
.Prote in 
(mg/ml) 
41 
224 
lgG 
(mg/ml) 
6.5 
55.3 
T ite rs 
lgG C3 
Xl280 
X5120 
X4 0 
X640 
IgG fraction" 11 10.6 X640 X80 
"Concent rated seru m was prepared with Amicon Diallow membrane 
YMlO. 
" Purified lgG fraction was obtai ned with protein A-Sepharose CL4B 
chromatography. 
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was 2960 CH50/ml before CVF injection, while after t h e CVF 
injection t he C3 level had dropped to 154 CH50/ml. 
DISCUSSION 
The importance of t he role of autoantibod ies and comple-
men t in t he pathogenesis of BP can be appreciated, as m ost 
BP patients have serum antibodies t hat react with specific 
antigen(s), and immunoglobulin and complement a re able to 
be detected at t he dermal-epidermal junction , above t he basal 
lamina and the lamina Iucida [6], or on t he basal surface of t he 
basal ce lls [7], t he ul trastructural site of DES. In contrast, it 
has been shown that BP sera failed to produce DES in organ 
culture, in spite of t he presence of complement [1] . Recen tly 
Naito, Morioka, and Ogawa [2] reported t hat DES was n ot 
obse rved in skin explants cu ltured wi th BP -y-globu lin fraction 
or BP lgG fraction, whereas BF from BP patients produced 
DES in vitro similar to t hose of BP skin lesions in vivo. They 
a lso studied t he effects of proteinase inhibitors (soybean trypsin 
inhibitor, pepstatin A, EDTA, a2- macroglobulin ) of DES. Fol-
lowing these in vitro observations, t hey suggested t hat other 
factors besides autoant ibodies and complement, such as en-
zy mes, are important for t he formation of DES. Concerni ng 
t he studies in vivo, Anhalt eta! (8) reported t hat BP autoanti -
bodies produced a visible blister in vivo when BP IgG fraction 
was injected in to rabbit cornea. But BP IgG fract ion injected 
intradermally into t he ear skin of rabbits failed to produce a 
blister condi t ion . However, Naito et a l [2] repo rted that DES 
was observed histologically 6 h after the injection of fresh BF 
or repeated (3 t imes) injection of BP sera (tite r of 1280) into 
Ha rtley gu inea pigs, and t he injection of BP sera pretreated 
with an antise rum of human IgG complete ly inhibited the 
formation of DES. These studies [2,8] suggest t hat a high local 
concent ration of BP antibodies may be required to produce 
DES in vivo. Recently, Gammon et al [9) have demonstrated 
an in vitro model of immune complex-mediated BMZ separa-
t ion cause by pemphigoid antibodies, serum complement, and 
periphera l blood leukocytes. T hese in vitro [9] and in vivo [2,8] 
studies suggested t hat t he role of antibodies, complement, and 
some enzymes released from migrated leukocytes is important 
for DES formation. 
In t hi s study, DES was frequently observed in t he skin of 
normal gu inea pigs after t he injection of concentrated BP seru m 
or BP IgG fraction, whereas the injection of serum did not 
cause DES (Table II ). These resul ts suggested t he important 
TABLE Ill. Effects of reagents on DES in uiuo 
Pret.reat.m ent 
Co ntrol (NaCI) 
Colchicine 
Cytochalasin B 
EDTA 
Betamet hasone 
0.9 % 
1 mM 
20 !IM 
1 mM 
4 mg/ml 
After the injection of cone. se rum 
(lgG fraction) (hours) 
3 6 12 24 
+ + + 
Two-tenth of a milliliter of each solu t ion was injected int raepider· 
mally 30 min before the injection of BP concentrated serum (!aG 
fraction) . 
TABLE II. DES in normal guinea pigs (in. uiuo) and effect of antihuman IgG on DES 
Injection 
Concentrated norma l human serum 
Normal lgG fract ions 
BP serum 
Concentrated BP se rum 
BP lgG fraction 
-------------------------------- ---- -- -------- --------- ---
0/8 
0/8 
0/4 
0/14 
0/ 10 
0/8 
0/8 
0/4 
0/14 
0/ 10 
Aft.e r the intraepide rmal injection (hours) 
6 
0/8 
0/8 
0/ 4 
5/14 
3/10 
l2 
0/8 
0/8 
0/4 
11/14 
7/10 
2~ 
0/8 
0/8 
0/4 
11 / 14 
7/10 
48 
1/8 
1/8 
0/ 4 
9/ 14 
6/10 
--------------------------------------------------------- ---- -------- ----- -- -- -------- ------------------------------
Concent rated normal human serum + anti human IgG 0/ 4 0/4 0/4 0/4 0/4 0/4 
March 1984 
FIG 1. Effects of some reagents on 
DES in vivo. DES was inhibited by col-
chicine, cytochalasin B, EDTA, and ste-
roid. Migration of PMN leukocytes was 
strongly inhibited by colchicine. A = 
DES. 
TABLE IV. Effects of complements on DES in vivo 
Experimental 
animals 
Normal guinea pigs 
C3-inactivated guinea pigs 
C4-deficient guinea pigs 
12 
7/10 
0/6 
2/6 
After the injection 
of BP lgG (hours) 
24 
7/10 
0/6 
2/6 
48 
6/10 
0/6 
2/6 
role of high-titer antibodies. In addition, some natural inhibi-
tors including armacroglobulin may affect the formation of 
DES, as lgG fraction , whose anti-BMZ lgG titer was lower 
t han BP sera, produced DES. The inhibitory effect of cYr 
macroglobulin on DES in vivo was reported previously [2]; 
however, concentrated serum which produces DES in vivo 
possibly contains a high level of a z·macroglobulin which exists 
in the serum and this inhibitor might be eluted out during the 
concentration procedure by Amicon. This phenomenon should 
be clarified in the near future. Histologic findings in the skin 
specimen produced with concentrated BP sera or BP lgG 
fraction showed the infiltration of inflammatory cells such as 
neutrophils, eosinophils, and some lymphocytes. We propose 
t hat these inflammatory cells secreted some kind of proteinase 
which may then produce DES. If this speculation is true , DES 
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will be inhibited by the inhibition of complement or the migra-
tion of PMN leukocytes. When colchicine, cytochalasin B, 
EDTA, or steroid was preinjected prior to the injection of lgG 
fraction, DES was inhibited by these reagents. Migrat ion of 
PMN leukocytes was strongly inhibited by colchicine, but 
slightly by cytochalasin B. Recently Gammon et al [10] have 
investigated the mechanisms of leukocyte attachment to the 
dermal-epidermal junction in vitro using skin sections. They 
also studied the effects of colchicine and cytochalasin B on 
leukocyte attachment. Their observations showed both re-
agents were ab le to inhibit the attachment and that cytochal -
asin B was more effective than co lchicine. Both their and our 
findings might strongly suggest t he important role of leukocytes 
for DES format ion. 
DES was inhibited by the inactivation of complements in 
vitro [2]. Jordon et al [11] reported that the complement 
activation by BP antibodies was through the classical pathway 
with a C3b amplification loop through the alternative pathway. 
Since mice contain a low level of complement compared to the 
normal gu inea pigs [12], we performed the mouse experiment 
t"o determine whether the participation of complement was 
critical in DES formation. We administrated the same dosage 
of BP IgG as we did into guinea pigs, into more than 10 mice 
intradermally. No DES formation was observed. In this study, 
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DES was inhibi ted completely in C3-inactivated guinea pigs 
(Table IV). These results suggested the important role of com-
plements in DES fo rmat ion. In C4-deficient gu inea pigs, 2 of 6 
animals were able to produce DES. These observations suggest 
DES can be produced by an alternative pathway. However, 
they do not suggest t hat the classical pathway is not playing a 
role in DES formation. There is some possibility that t he 
classical pathway may be working cooperatively with an alter -
native pathway. Thi s should be clarified in the near fu ture by 
experimentation with an increased number of animals. 
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